Furthermore, LrB can reduce inflammation and insulin resistance in individuals with PCOS by inhibiting NLRP3, Caspase-1, TNF-α, IL-6, IL-1β, and IL-18 and increasing the expressions of GPR120, LKB1, and AMPK. Here, STK11 is linked to polycystic ovary syndrome.